AbbVie Inc - Company Snapshot & SWOT Analysis

Publication ID:

NAV0319006

Publication Date:

March 06, 2019

Pages:

Countries:

Global [1]

As per NAVADHI Market Research, the global pharmaceutical industry [2] will we worth USD 1.57 trillion by 2023.

AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories. The company operates in more than 75 countries.

AbbVie Inc. 2018 Revenue Performance at a glance

AbbVie’s products are focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson’s disease and multiple sclerosis; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. AbbVie also has a pipeline of promising new medicines in clinical development across such important medical specialties as immunology, oncology and neurology, with additional targeted investment in cystic fibrosis and women’s health.

AbbVie Inc. reported revenue of USD 32.733 billion for the FY 2018 which saw an increase of 16% compared to FY 2017.

Company's global sales were impacted by the launch of several direct biosimilar drugs. These drugs are launched at much cheaper price anticipated by AbbVie resulting decline in sales in Europe and other international markets.

AbbVie Inc. registered highest revenue from immunology (Humira) at USD 19.936 billion. Humira continue to perform better in the U.S. market, drug sales are expected to rise approximately 7% in 2019, which is less than growth of 10% in 2018 due to lighter price contribution for the year.

Spanning over 27 pages and 10 exhibits, “AbbVie Inc - Company Snapshot & SWOT Analysis” report provides value chain analysis, financial performance, business strategy and SWOT analysis for company.

Scope of the AbbVie Inc - Company Snapshot & SWOT Analysis Report

This report provides detailed information about AbbVie Inc including value chain analysis, financial performance, business strategy and SWOT analysis.
he report identifies the growth drivers and inhibitors for global pharmaceutical market.
This report provides information about current and future trends for global pharmaceutical market.

1. Executive Summary

Scope of the AbbVie Inc.- Company Snapshot & SWOT Analysis Report

Research Methodology

2. Growth Drivers and Inhibitors for Global Pharmaceuticals Market

3. Company Profile

3.1 AbbVie Inc.

3.1.1. Company Profile

3.1.2 AbbVie Inc. in Global Pharmaceuticals Manufacturing Value Chain

3.1.3 AbbVie Inc.: Financial Performance

3.1.3.1 AbbVie Inc.: Overall Revenue FY 2013-FY 2019 (in USD billion)

3.1.3.2 AbbVie Inc.: Geography-Wise Revenue FY 2018 (in USD billion)

3.1.3.3 AbbVie Inc.: Therapy Area-Wise Revenue FY 2018 (in USD billion)

3.1.4 AbbVie Inc.: Business Strategy

3.1.4.1 Product Level Strategy

3.1.5 SWOT Analysis of AbbVie Inc.

Strengths

Weaknesses

Opportunities

Threats

4. Current and Future Trends in Pharmaceutical Market

List of Exhibits

Notes

List of Exhibits

Exhibit 2.1 Growth Drivers and Inhibitors for Global Pharmaceuticals Market

Exhibit 3.1 Key information of AbbVie Inc.

Exhibit 3.2 Contact Information of AbbVie. Inc.

Exhibit 3.3 AbbVie. Inc. in Global Pharmaceuticals Manufacturing Value Chain

Exhibit 3.4 Revenue of AbbVie Inc. FY 2013- FY 2019 (in USD billion)

Exhibit 3.5 Revenue Growth of AbbVie Inc. FY 2014-FY 2019 (in %)

Exhibit 3.6 Geography-Wise Revenue of AbbVie Inc. in FY 2018 (in USD billion)

Exhibit 3.7 Therapy Area-Wise Revenue of AbbVie Inc. in FY 2018 (in USD billion)

Exhibit 3.8 Therapy Area and Geography Area-Wise Revenue of AbbVie Inc. FY 2018 (in USD billion)

Exhibit 3.9 SWOT Analysis of AbbVie Inc.

AbbVie Inc.

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Enterprise license fee.

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Enterprise license fee.

Enterprise License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.